KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus as second-line (2L) therapy

S.-B. Kim, T. Doi, K. Kato, J. Chen,M. Shah,A. Adenis,S. Luo, S. Qin, T. Kojima,J.-P. Metges, E. Francois, K. Muro,Y. Cheng,Z. Li, X. Yuan,R. Wang,Y. Cui,P. Bhagia, L. Shen

ANNALS OF ONCOLOGY(2019)

引用 5|浏览40
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要